|
Volumn 362, Issue 9388, 2003, Pages 998-999
|
Nesiritide in acute heart failure [3] (multiple letters)
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIARRHYTHMIC AGENT;
ANTICOAGULANT AGENT;
BETA ADRENERGIC RECEPTOR BLOCKING AGENT;
CALCIUM CHANNEL BLOCKING AGENT;
DIGOXIN;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
DIURETIC AGENT;
DOBUTAMINE;
GLYCERYL TRINITRATE;
MILRINONE;
NESIRITIDE;
NITRATE;
NITROPRUSSIDE SODIUM;
RECOMBINANT BRAIN NATRIURETIC PEPTIDE;
UNCLASSIFIED DRUG;
BRAIN NATRIURETIC PEPTIDE;
NATRIURETIC FACTOR;
ACUTE HEART FAILURE;
CARDIOVASCULAR DISEASE;
CLINICAL TRIAL;
COST OF ILLNESS;
DIAGNOSTIC PROCEDURE;
DOSE RESPONSE;
DRUG ACTIVITY;
DRUG COST;
DRUG DOSE REDUCTION;
DRUG EFFICACY;
DRUG INDICATION;
DRUG SAFETY;
DYSPNEA;
ELECTROCARDIOGRAM;
HEART RATE;
HEART VENTRICLE ARRHYTHMIA;
HOSPITAL ADMISSION;
HUMAN;
HYPOTENSION;
LENGTH OF STAY;
LETTER;
LUNG CAPILLARY PRESSURE;
PHYSICAL EXAMINATION;
PRIORITY JOURNAL;
TACHYCARDIA;
VALSALVA MANEUVER;
ACUTE DISEASE;
CARDIAC OUTPUT, LOW;
CLINICAL TRIAL (TOPIC);
COMPARATIVE STUDY;
HEART FAILURE;
METHODOLOGY;
STANDARDS;
STATISTICS AND NUMERICAL DATA;
TREATMENT OUTCOME;
ACUTE DISEASE;
CARDIAC OUTPUT, LOW;
CLINICAL TRIALS AS TOPIC;
HEART FAILURE;
HUMANS;
NATRIURETIC AGENTS;
NATRIURETIC PEPTIDE, BRAIN;
NITROGLYCERIN;
RESEARCH DESIGN;
TREATMENT OUTCOME;
|
EID: 0141540745
PISSN: 01406736
EISSN: None
Source Type: Journal
DOI: 10.1016/S0140-6736(03)14380-2 Document Type: Letter |
Times cited : (7)
|
References (0)
|